The Patent Finder
US

Systems and Methods for Analyzing Viral Nucleic Acids

US 11,702,708 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Nov 19, 2036 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Jul 24, 2020 as application 16/937,827 · Granted Jul 18, 2023
Base term plus 290 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2016 2036
Clock starts
Feb 3, 2016
Ends no later than
Nov 19, 2036
Granted
Jul 18, 2023
base term patent term adjustment Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
290
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 290 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 3, 2016, when application 15/014,500, the earliest non-provisional in its chain, was filed (this one was filed Jul 24, 2020)Feb 3, 2036High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+290 days, USPTO patent term adjustment recordNov 19, 2036High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Nov 19, 2036Medium confidence

This family

US 10,724,110In force
Mar 2037
Mar 2037
US 11,702,708this patent
no later than Nov 2036
no later than Nov 2036
US 12,173,374In force
Feb 2036
Feb 2036
Application 18/947,751Pending
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Oct 30, 2020
Reel 54225, frame 37
Locke, Devin; Szamel, PiotrSeven Bridges Genomics Inc.Assignment of Assignor's Interest
Mar 30, 2022
Reel 59554, frame 165
Seven Bridges Genomics Inc.Imperial Financial Services B.V.Security Interest
May 24, 2022
Reel 60173, frame 792
Imperial Financial Services B.V.Seven Bridges Genomics Inc.Release of Security Interest
May 24, 2022
Reel 60173, frame 803
Seven Bridges Genomics Inc.Imperial Financial Services B.V.Security Interest
Aug 2, 2022
Reel 61055, frame 78
Imperial Financial Services B.V.Seven Bridges Genomics Inc.Release of Security Interest
Aug 4, 2022
Reel 61084, frame 786
Pieriandx, Inc.; Seven Bridges Genomics Inc.Orbimed Royalty & Credit Opportunities III, LPSecurity Interest
Oct 9, 2026
reel/frame not recorded
Orbimed Royalty & Credit Opportunities III, LPPieriandx, Inc.Release of Security Interest
Oct 9, 2026
reel/frame not recorded
Orbimed Royalty & Credit Opportunities III, LPSeven Bridges Genomics Inc.Release of Security Interest
Oct 9, 2026
Reel 76676, frame 119
Orbimed Royalty & Credit Opportunities III, LPPieriandx, Inc.; Seven Bridges Genomics Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited